Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990

Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019 Publisher Pubmed

Tondroanamag F¹ ; Noori M^{2, 3} ; Nejadghaderi SA^{4, 5} ; Sullman MJM^{6, 7} ; Grieger JA^{8, 9} ; Kolahi AA¹⁰ ; Safiri S^{1, 11}

Show Affiliations

1. Social Determinants of Health Research Center, Department of Community Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2. Student Research Committee, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
3. Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Research Center for Integrative Medicine in Aging, Aging Research Institute, Tabriz University of Medical Sciences, Tabriz, Iran
5. Systematic Review and Meta-analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran
6. Department of Life and Health Sciences, University of Nicosia, Nicosia, Cyprus
7. Department of Social Sciences, University of Nicosia, Nicosia, Cyprus
8. Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia
9. Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia
10. Social Determinants of Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
11. Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Cancer Medicine Published:2023

Abstract

Background: The present study reported the cancer deaths and disability-adjusted life years (DALYs) that were attributable to high fasting plasma glucose (HFPG) in the Middle East and North Africa (MENA) region by country, age, sex, cancer type and Socio-demographic Index (SDI), from 1990 to 2019. Methods: Global Burden of Disease (GBD) 2019 data were used to report the cancer-related deaths and DALYs that were attributable to HFPG, for all MENA countries over the period 1990–2019. The results were presented as numbers, population attributable fractions (PAFs) and rates (per 100,000) with 95% uncertainty intervals. Results: In 2019, there were an estimated 19.8 thousand (5.5–40.2) cancer deaths attributable to HFPG in MENA, which represents 4.7% (1.3–9.3) of all cancer-related deaths. The number of regional DALYs due to HFPG-related cancers was 462.2 thousand (127.3–959.5), which represents 3.8% (1.1–7.6) of all cancer-related DALYs in 2019. From 1990 to 2019, the age-standardized DALY rate of cancers attributable to HFPG (per 100,000) grew from 56.3 (14.6–121.1) to 107.0 (29.8–220.8), which was a 90.1% (64.4–127.8) increase. In 2019, the highest age-standardized DALY rate of cancers attributable to HFPG was in Qatar (270.4) and the lowest was in Sudan (75.3). The DALY rate of cancers attributable to HFPG increased with age, peaking for males in the 70–74 age group and for females in the 75–79 age group, and then decreased for both sexes. A broadly positive relationship was found between the national SDI and the national age-standardized DALY rate of all cancers attributable to FPG over the measurement period. Conclusions: The burden of HFPG-related cancers has increased over the past three decades in MENA, and was higher than the global average in multiple age groups. Implementing a battery of preventive measures and therapeutic interventions is suggested to address the adverse effects of this modifiable risk factor. © 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Related Docs

View other Related Docs

1. Global, Regional and National Burden of Cancers Attributable to High Fasting Plasma Glucose in 204 Countries and Territories, 1990-2019, Frontiers in Endocrinology (2022)

2. Burden of Female Breast Cancer in The Middle East and North Africa Region, 1990–2019, Archives of Public Health (2022)

3. Global, Regional, and National Burden of Colorectal Cancer and Its Risk Factors, 1990–2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Gastroenterology and Hepatology (2022)

4. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019 a Systematic Analysis for the Global Burden of Disease Study 2019, JAMA Oncology (2022)

5. National and Subnational Burden of Female and Male Breast Cancer and Risk Factors in Iran From 1990 to 2019: Results From the Global Burden of Disease Study 2019, Breast Cancer Research (2023)

6. Burden of Ischemic Heart Disease and Its Attributable Risk Factors in North Africa and the Middle East, 1990 to 2019: Results From the Gbd Study 2019, Journal of the American Heart Association (2024)

7. Global, Regional, and National Burden of Cancers Attributable to Excess Body Weight in 204 Countries and Territories, 1990 to 2019, Obesity (2022)

8. The Global Burden of Cancer Attributable to Risk Factors, 2010–19: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet (2022)

Experts (# of related papers)

View all Related Experts

Bagher Larijani (50)

Farshad Farzadfar (49)

Style	Citing Format
MLA	Tondroanamag F, et al.. "Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019." Cancer Medicine, vol. 12, no. 8, 2023, pp. 10031-10044.
APA	Tondroanamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, Safiri S (2023). Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019. Cancer Medicine, 12(8), 10031-10044.
Chicago	Tondroanamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, Safiri S. "Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019." Cancer Medicine 12, no. 8 (2023): 10031-10044.
Harvard	Tondroanamag F et al. (2023) 'Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019', Cancer Medicine, 12(8), pp. 10031-10044.
Vancouver	Tondroanamag F, Noori M, Nejadghaderi SA, Sullman MJM, Grieger JA, Kolahi AA, et al.. Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019. Cancer Medicine. 2023;12(8):10031-10044.
BibTex	@article{ author = {Tondroanamag F and Noori M and Nejadghaderi SA and Sullman MJM and Grieger JA and Kolahi AA and Safiri S}, title = {Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019}, journal = {Cancer Medicine}, volume = {12}, number = {8}, pages = {10031-10044}, year = {2023} }
RIS	TY - JOUR AU - Tondroanamag F AU - Noori M AU - Nejadghaderi SA AU - Sullman MJM AU - Grieger JA AU - Kolahi AA AU - Safiri S TI - Burden of Cancers Attributable to High Fasting Plasma Glucose in the Middle East and North Africa Region, 1990–2019 JO - Cancer Medicine VL - 12 IS - 8 SP - 10031 EP - 10044 PY - 2023 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract